The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Quince Therapeutics Inc (NASDAQ: QNCX) closed at $3.35 in the last session, up 2.76% from day before closing price of $3.26. In other words, the price has increased by $2.76 from its previous closing price. On the day, 0.47 million shares were traded. QNCX stock price reached its highest trading level at $3.35 during the session, while it also had its lowest trading level at $3.2.
Ratios:
We take a closer look at QNCX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 16.97 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
. In the most recent recommendation for this company, Citizens JMP on August 05, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $9.
On March 24, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 26 ’25 when LUCA BENATTI bought 50,000 shares for $3.46 per share.
Benatti Luca sold 50,000 shares of QNCX for $173,500 on Dec 26 ’25. The Director now owns 39,179 shares after completing the transaction at $3.47 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QNCX now has a Market Capitalization of 186532976 and an Enterprise Value of 178237984.
Stock Price History:
The Beta on a monthly basis for QNCX is 1.15, which has changed by 0.7340425 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, QNCX has reached a high of $4.55, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is 24.05%, while the 200-Day Moving Average is calculated to be 90.31%.
Shares Statistics:
According to the various share statistics, QNCX traded on average about 676.77K shares per day over the past 3-months and 508660 shares per day over the past 10 days. A total of 54.49M shares are outstanding, with a floating share count of 48.30M. Insiders hold about 13.25% of the company’s shares, while institutions hold 20.78% stake in the company. Shares short for QNCX as of 1765756800 were 2064545 with a Short Ratio of 3.05, compared to 1763078400 on 1365905. Therefore, it implies a Short% of Shares Outstanding of 2064545 and a Short% of Float of 4.14.
Earnings Estimates
Currently, 3.0 analysts are dedicated to thoroughly evaluating and rating the performance of Quince Therapeutics Inc (QNCX) in the stock market.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.15 and low estimates of -$0.23. Analysts are recommending an EPS of between -$1.03 and -$1.15 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.72, with 4.0 analysts recommending between -$0.11 and -$1.24.
